UBS’s EnteroMedics ETRM Stock Holding History
Bought
Maintained
Sold
Other funds holding ETRM
IHM
UBS's ETRM Position: Q3 2014 in Review
UBS reduced its EnteroMedics (ETRM) stake by 96% in Q3 2014, selling an estimated $68.9K and leaving 2 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #10121.
UBS first reported a position in ETRM in Q2 2013 and has held it in 4 quarters since. The position peaked at $80K in Q2 2014. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.
- UBS held 2 shares of EnteroMedics worth $2K as of Q3 2014.
- UBS sold 47 EnteroMedics shares in Q3 2014, an estimated $68.9K.
- EnteroMedics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10121 holding.
- UBS first reported a position in EnteroMedics in Q2 2013 and has held it in 4 quarters since.
- UBS's EnteroMedics position peaked at $80K in Q2 2014.
- 49 funds tracked by Wall St. Rank held EnteroMedics as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.